UNSPSC 51283949: Sulfamerazine sodium

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H11N4O2S.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JOV4UJY07O, chemically known as sulfanilamide, n(sup 1)-(4-methyl-2-pyrimidinyl)- but more generally known as sulfamerazine sodium, which bears US NIH Compound Identifier 5325. European Medicines Agency schedules Sulfamerazine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10709MIG.

UNSPSC 51283949 Sulfamerazine sodium is a Commodity code for a specific pharmaceutical active ingredient, yet the recent state and local opportunities posted under this code do not reflect procurement of sulfamerazine sodium itself. Instead, the tagged solicitations show state and local health agencies acquiring finished pharmaceutical products and medical supplies — specifically antibiotic tablets (Doxycycline Hyclate, Ciprofloxacin Hydrochloride) and opioid-reversal and drug-deactivation equipment (Naloxone and Safe Drug Deactivation Systems). The mismatch suggests either tagging inconsistency in the state procurement databases or that sulfamerazine sodium is being sourced as a component within larger pharmaceutical supply contracts rather than as a standalone chemical procurement. State and local issuing bodies using this code include state health departments and county health authorities pursuing pharmaceutical inventory replenishment through competitive bidding and cooperative purchasing consortia.

The recent activity spans two states: Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Bid 26-482DPH-PREPDB53392, completed August 28, 2026, IFB process) for antibiotic tablet supply under a 12-month initial term with two renewal options. Seminole County, Florida released an IFB (60459723LAS, due July 26, 2023) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building in Sanford, under a two-year initial contract with one-year renewal option and potential FEMA funding. Neither opportunity directly reflects sulfamerazine sodium procurement; the code's current state and local activity does not align with its nominal commodity definition.